Hepatitis C in Egypt – past, present, and future

References

• El-ZanatyFWayAEgypt Demographic and Health Survey 2008Cairo, EgyptMinistry of Health, El-Zanaty and Associates, and Macro International2009431
   Google Scholar
• FrankCMohamedMStricklandGTThe role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptLancet2000355920788789110752705
   PubMed Web of Science ®Google Scholar
• ShepardCWFinelliLAlterMJGlobal epidemiology of hepatitis C virus infectionLancet Infect Dis20055955856716122679
   PubMed Web of Science ®Google Scholar
• WanisHHCV treatment in Egypt – why cost remains a challenge?Cairo, EgyptEgyptian initiative for personal rights [serial on the Internet]201414 Available from: http://www.eipr.org/sites/default/files/pressreleases/pdf/hcv_treatment_in_egypt.pdfAccessed June 16, 2016
   Google Scholar
• WakedIDossWEl-SayedMThe current and future disease burden of chronic hepatitis C virus infection in EgyptArab J Gastroenterol2014152455225097045
   PubMed Web of Science ®Google Scholar
• RazaviHWakedISarrazinCThe present and future disease burden of hepatitis C virus with today’s treatment paradigmJ Viral Hepat201421Suppl 1345924713005
   PubMed Web of Science ®Google Scholar
• MohamoudYMumtazGRiomeSMillerDRaddadLThe epidemiology of Hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infect Dis [serial on the Internet]201313288 Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-288Accessed May 16, 2016
   PubMed Web of Science ®Google Scholar
• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• NHS Choices [page on the Internet]Complications of Hepatitis C2013 Available from: http://www.nhs.uk/Conditions/Hepatitis-C/Pages/Complications.aspxAccessed July 10, 2015
   Google Scholar
• KimCWChangKMHepatitis C Virus: virology and life cycleClin Mol Hepatol2013191172523593605
   PubMedGoogle Scholar
• ZhaoLHepatits C virus: molecular pathways and treatmentsFoster, USAOMICS Group eBooks2014313 Available from: http://www.esciencecentral.org/ebooks/hepatitis/pdf/hepatitis-c-virus-molecular-pathways-and-treatments.pdfAccessed May 16, 2016
   Google Scholar
• AsterJCAbbasAKRobbinsSLKumarVRobbins Basic Pathology9th edPhiladelphia, PAElsevier Saunders2013
   Google Scholar
• DarwishMARaoufTARushdyPConstantineNTRaoMREdelmanRRisk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donorsAm J Trop Med Hyg19934944404477692754
   PubMed Web of Science ®Google Scholar
• ArthurRRHassanNFAbdallahMYHepatitis C antibody prevalence in blood donors in different governorates in EgyptTrans R Soc Trop Med Hyg19979132712749231192
   PubMed Web of Science ®Google Scholar
• Abdel-AzizFHabibMMohamedMHepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalenceHepatology200032111111510869297
   PubMed Web of Science ®Google Scholar
• DarwishMFarisRClemensJRaoMEdelmanRHigh seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot studyAm J Trop Med Hyg19965465545588686770
   PubMed Web of Science ®Google Scholar
• HibbsRCorwinAHassanNThe epidemiology of antibody to hepatitis C in EgyptJ Infect Dis199316837897908394867
   PubMed Web of Science ®Google Scholar
• El-SayedNGomatosPRodierGSeroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of EgyptAm J Trop Med Hyg19965521791848780457
   PubMed Web of Science ®Google Scholar
• Abdel-WahabMFZakariaSKamelMHigh seroprevalence of hepatitis C infection among risk groups in EgyptAm J Trop Med Hyg19945155635677527186
   PubMed Web of Science ®Google Scholar
• StruthersAFrom schistosomiasis to hepatitis C: the spread of HCV in EgyptMed J Ther Africa200713213221 Available from: http://mjota.org/images/SpreadofHCVEgypt.pdfAccessed February 16, 2016
   Google Scholar
• Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Parasitic Diseases. [homepage on the Internet]Schistosomiasis public information fact sheet [updated November 7, 2012] Available from: http://www.cdc.gov/parasites/schistosomiasis/Accessed June 01, 2016
   Google Scholar
• StricklandGLiver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factorsHepatology200643591592216628669
   PubMed Web of Science ®Google Scholar
• RaoMRNaficyABDarwishMAFurther evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in EgyptBMC Infect Dis200222912464161
   PubMed Web of Science ®Google Scholar
• FrankCMohamedMKStricklandGTThe role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptLancet2000355920788789110752705
   PubMed Web of Science ®Google Scholar
• BallesterJMRiveroRAVillaescusaRHepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patientsJ Clin Virol200534Suppl 2S39S4616461239
   PubMedGoogle Scholar
• DarwishMFarisRDarwishNHepatitis C and cirrhotic liver disease in the Nile delta of Egypt: a community-based studyAm J Trop Med Hyg2001643–414715311442209
   PubMed Web of Science ®Google Scholar
• HoofnagleJHepatitis C: the clinical spectrum of diseaseHepatology1997263 Suppl 115S20S9305658
   PubMed Web of Science ®Google Scholar
• RuanePAinDStrykerRSofosbuvir plus ribavirin for the treatment of chronic genotype 4 Hepatitis C virus infection in patients of Egyptian ancestryJ Hepatol20156251040104625450208
   PubMed Web of Science ®Google Scholar
• MuirAJThe rapid evolution of treatment strategies for hepatitis CAm J Gastroenterol2014109562863524732866
   PubMed Web of Science ®Google Scholar
• LawitzEMangiaAWylesDSofosbuvir for previously untreated chronic hepatitis C infectionN Engl J Med2013368201878188723607594
   PubMed Web of Science ®Google Scholar
• JacobsonIGordonSKowdleyKSofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment optionsN Engl J Med2013368201867187723607593
   PubMed Web of Science ®Google Scholar
• American Association for the Study of Liver Diseases and the Infectious Diseases Society of AmericaRecommendations for testing, managing, and treating hepatitis C2014 Available from: http://www.hcvguidelines.org/Accessed June 16, 2016
   Google Scholar
• European Association for the Study of the LiverEASL clinical practice guidelines: management of hepatitis C virus infectionJ Hepatology201463pt 392420
   Web of Science ®Google Scholar
• WHO [fact page on the Internet]Guidelines for screening, care and treatment of persons with hepatitis C infectionPublications on Viral Hepatits2014 Available from: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/Accessed June 12, 2016
   Google Scholar
• DossWShihaGHassanyMSofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genome 4J Hepatol2015633584585
   Web of Science ®Google Scholar
• WanisHHusseinAEl ShibinyAHCV treatment in Egypt – why cost remains a challenge Egyptian initiative for personal rights2014618 Available from: http://www.eipr.org/sites/default/files/pressreleases/pdf/hcv_treatment_in_egypt.pdfAccessed June 16, 2016
   Google Scholar
• DossWMohammedMEsmatGEgyptian National Control Strategy for Viral Hepatitis 2008–20122008 Available from: http://www.hepnile.org/images/stories/doc/NSP_10_April_2008_final2.pdfAccessed June 16, 2016
   Google Scholar
• FickMHirschlerBGilead offers Egypt new hepatitis C drug at 99 percent discountReuters [serial on the internet]2014 Available from: http://www.reuters.com/article/2014/03/21/us-hepatitis-egypt-gilead-sciences-idUSBREA2K1VF20140321Accessed June 16, 2016
   Google Scholar
• HuiAYFriedmanSLMolecular basis of hepatic fibrosisExpert Rev Mol Med200355123
   Google Scholar